DOI QR코드

DOI QR Code

The Evaluation of Fabrication Parameters Process Effect on the Formation of Poly(lactic-co-glycolic acid) (PLGA) Microspheres

  • Bao, Trinh-Quang (Department of Biomedical Engineering and Materials, College of Medicine, Soonchunhyang University) ;
  • Lee, Byong-Taek (Department of Biomedical Engineering and Materials, College of Medicine, Soonchunhyang University)
  • 투고 : 2010.08.25
  • 심사 : 2011.03.02
  • 발행 : 2011.05.20

초록

In this study, a poly(lactic-co-glycolic acid) (PLGA) microspheres was fabricated using emulsion solvent evaporation technique. During the procedure fabrication, some parameters process have effected on the formation of micro-carriers. The structure and morphology of micro-carriers were evaluated by SEM observation. Beside, heparin incorporated into microspheres was determined using toluidine blue method. Specifically, the effects of some parameters process such as ultrasonic levels, PLGA concentrations and freeze-dry times on the size, structure, porous formation and heparin entrapment of micro-carriers were studied carefully. We found that, the morphology and structure of carriers were influenced by the all above parameters. The diameter of the carriers varied from 20 to 400 ${\mu}M$ depending on experimental conditions. At suitable freeze-dry time, the pores were automatically formation on surface of microspheres with a significantly in the numbers of pore. After heparin incorporated porous PLGA microspheres, it was suggested that the highly heparin incorporated into porous PLGA microspheres could enhance of angiogenesis for tissue regeneration easily.

키워드

참고문헌

  1. Manca, M. L.; Mourtas, S.; Dracopoulos, V.; Fadda, A. M.; Antimisiaris, S. G. Colloids and Surfaces B: Biointerfaces 2008, 68, 220-231.
  2. Langer, R. Nature 1998, 392, 1-5. https://doi.org/10.1038/31985
  3. Leong, K. W.; Amore, P. D.; Marletta, M.; Langer, R. Journal of Biomedical Materials Research 1986, 20, 51-64. https://doi.org/10.1002/jbm.820200106
  4. Chung, H. J.; Park, T. G. Tissue Engineering: Part A 2008, 15, 1392-1400.
  5. Chengji, C.; Steven, P. S. Pharmaceutical Research 2007, 24, 2381-2393. https://doi.org/10.1007/s11095-007-9378-1
  6. Chung, H. J.; Kim, H. K.; Joon, J. J.; Park, T. G. Pharmaceutical Research 2006, 23, 1835-1841. https://doi.org/10.1007/s11095-006-9039-9
  7. Kuo, Y. C.; Shih, K. H. Colloids and Surfaces B: Biointerfaces 2009, 71, 282-287. https://doi.org/10.1016/j.colsurfb.2009.02.021
  8. Yi, Y. Y.; Tai, S. C.; Ngee, P. N. Biomaterials 2001, 22, 231-241. https://doi.org/10.1016/S0142-9612(00)00178-2
  9. Zonghua, L.; Yanpeng, J.; Fanna, L.; Ziyong, Z. Journal of Biomedical Materials Research Part A 2007, 83A, 206-812.
  10. Hoffart, V.; Ubrich, N.; Simonin, C.; Babak, V.; Vigneron, C.; Hoffman, M.; Lecompte, T.; Maincent, P. Drug Development and Industrial Pharmacy 2002, 28, 1091-1099. https://doi.org/10.1081/DDC-120014576
  11. Yu, H. L.; Chiung, H. C.; Yu, S. W.; Yuan, M. H.; Shu, F. C.; Yi, J. C. Biomaterials 2009, 30, 3332-3342. https://doi.org/10.1016/j.biomaterials.2009.02.036
  12. Yi, Y. Y.; Tai, S. C.; Ngee, P. N. Biomaterials 2001, 22, 231-241. https://doi.org/10.1016/S0142-9612(00)00178-2
  13. Sergio, F.; Hans, P. M.; Bruno, G. Journal of Controlled Release 2005, 102, 313-332. https://doi.org/10.1016/j.jconrel.2004.10.015